Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-16 11:28 am Purchase | 13G | TENAX THERAPEUTICS INC PAR TENX | CVI Investments Inc. | 204,027 9.9% | 204,027 (New Position) | View |
2024-02-14 2:14 pm Purchase | 13G | EVOFEM BIOSCIENCES INC PAR EVFM | CVI Investments Inc. | 102,799 0.9% | 102,799 (New Position) | View |
2024-02-14 2:14 pm Unchanged | 13G | SIDUS SPACE INC SIDU | CVI Investments Inc. | 0 0% | 0 (Unchanged) | View |
2024-02-14 2:14 pm Unchanged | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | CVI Investments Inc. | 0 0% | 0 (Unchanged) | View |
2024-02-14 2:14 pm Sale | 13G | BITFARMS LTD COM BITF | CVI Investments Inc. | 9,259,260 2.8% | -9,259,260 (-50.00%) | View |
2024-02-14 2:14 pm Purchase | 13G | ENSERVCO CORPORATION ENSV | CVI Investments Inc. | 1,411,740 4.9% | 411,740 (+41.17%) | View |
2024-02-14 2:14 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | CVI Investments Inc. | 0 0% | -5,500,000 (Position Closed) | View |
2024-02-14 2:14 pm Unchanged | 13G | DUET ACQUISITION CORP DUET | CVI Investments Inc. | 0 0% | 0 (Unchanged) | View |
2024-02-14 2:14 pm Purchase | 13G | ADITXT INC PAR $0.001 ADTX | CVI Investments Inc. | 2,066 0.5% | 2,066 (New Position) | View |
2024-02-14 2:14 pm Purchase | 13G | RYVYL INC PAR $0.001 RVYL | CVI Investments Inc. | 596,135 9.9% | 596,135 (New Position) | View |
2024-02-14 2:14 pm Purchase | 13G | NOVA LIFESTYLE INC PAR $ NVFY | CVI Investments Inc. | 74,300 4.3% | 74,300 (New Position) | View |
2024-02-14 2:14 pm Purchase | 13G | ICORECONNECT INC ICCT | CVI Investments Inc. | 382,363 4.1% | 382,363 (New Position) | View |
2024-02-14 2:14 pm Unchanged | 13G | GENETIC TECHNOLOGIES LTD SPONS GENE | CVI Investments Inc. | 0 0% | 0 (Unchanged) | View |
2024-02-14 2:14 pm Purchase | 13G | EBET INC EBET | CVI Investments Inc. | 65,359 0.4% | 65,359 (New Position) | View |
2024-02-14 2:14 pm Purchase | 13G | VERSUS SYS INC NO PAR VS | CVI Investments Inc. | 100,000 3.8% | 100,000 (New Position) | View |
2024-02-14 2:14 pm Sale | 13G | GENPREX INC GNPX | CVI Investments Inc. | 3,089,092 4.9% | -376,255 (-10.86%) | View |
2024-02-14 2:14 pm Purchase | 13G | EOS ENERGY ENTERPRISES INC EOSE | CVI Investments Inc. | 9,800,990 4.9% | 1,800,990 (+22.51%) | View |
2024-02-14 2:14 pm Purchase | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | CVI Investments Inc. | 414,827 9.9% | 207,254 (+99.85%) | View |
2024-02-14 2:14 pm Sale | 13G | GAMIDA CELL LTD GMDA | CVI Investments Inc. | 6,966,279 4.9% | -33,721 (-0.48%) | View |
2024-02-14 2:14 pm Unchanged | 13G | EBANG INTL HLDGS INC EBON | CVI Investments Inc. | 343,332 6.8% | 0 (Unchanged) | View |